Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
20.96
-0.68 (-3.14%)
At close: Feb 27, 2026, 4:00 PM EST
20.80
-0.16 (-0.76%)
After-hours: Feb 27, 2026, 7:55 PM EST
Apellis Pharmaceuticals Employees
As of December 31, 2025, Apellis Pharmaceuticals had 739 total employees, including 733 full-time and 6 part-time employees. The number of employees increased by 29 or 4.08% compared to the previous year.
Employees
739
Change (1Y)
29
Growth (1Y)
4.08%
Revenue / Employee
$1,358,298
Profits / Employee
$30,295
Market Cap
2.68B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 627 |
| Beam Therapeutics | 511 |
| Travere Therapeutics | 385 |
| Wave Life Sciences | 288 |
| Dyne Therapeutics | 240 |
| Vera Therapeutics | 224 |
| Catalyst Pharmaceuticals | 181 |
| Liquidia | 170 |
APLS News
- 4 days ago - Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 days ago - Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 9 days ago - Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting - GlobeNewsWire
- 18 days ago - Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 - PRNewsWire
- 5 weeks ago - Apellis Valuation Ignores Empaveli Potential, Says Analyst - Benzinga
- 6 weeks ago - Apellis Pharmaceuticals, Inc. (APLS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha